1-8 of 8
pancreatic cancer stage iv
Close
Sort by
Journal Articles

Impact of Splanchnic Vein Thrombosis on Mortality in Patients with Advanced Pancreatic Cancer

Amber Afzal, MD, Suhong Luo, MS, Theodore S. Thomas, MD MPHS, Kristen M. Sanfilippo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4685.
https://doi.org/10.1182/blood-2018-99-111995
Published: 2018
Journal Articles

Development of Anti-IL-1R3 Monoclonal Antibodies for Treating Cancer and IL-1 Family-Mediated Inflammation

Jesper F Højen, MD, Megan K Taylor, Tania Azam, Stephan Fischer, Daniel A Pollyea, MD, Craig T Jordan, PhD, Charles A. Dinarello, MD
Journal: Blood
Blood (2016) 128 (22): 5224.
https://doi.org/10.1182/blood.V128.22.5224.5224
Published: 2016
Journal Articles

A Single Center Retrospective Analysis of Outcomes Following the Use of 4-Factor Prothrombin Complex Concentrate for Warfarin Reversal in Real-Life Settings

Ranjit Joseph, MD, Amanda Strickland, James Burner, MD, Sean Yates, MD, William Tharpe, PharmD, Ravindra Sarode, MD
Journal: Blood
Blood (2014) 124 (21): 1561.
https://doi.org/10.1182/blood.V124.21.1561.1561
Published: 2014
Journal Articles

MM-005: A Phase 1 Trial Of Pomalidomide, Bortezomib, and Low-Dose Dexamethasone (PVD) In Relapsed and/Or Refractory Multiple Myeloma (RRMM)

Paul G. Richardson, MD, Craig C. Hofmeister, MD, David Siegel, MD, PhD, Sagar Lonial, MD, Jacob P. Laubach, MD, Yvonne A. Efebera, MD, David H. Vesole, MD, PhD, Ajay K. Nooka, MD, MPH, Jacalyn Rosenblatt, MD, MSc, Noopur Raje, MD., Mohamed H. Zaki, MD, PhD, Ye Hua, MD, MPH, Yan Li, PhD, Sheetal Shah, BA, Jianming Wang, PhD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2013) 122 (21): 1969.
https://doi.org/10.1182/blood.V122.21.1969.1969
Published: 2013
Journal Articles

Early Results Of a Phase II Study Of Lenalidomide and Rituximab As Frontline Treatment Of Patients With Chronic Lymphocytic Leukemia

Paolo Strati, MD, Michael J. Keating, MD, Christina Hinojosa, Stefan Faderl, MD, Susan C. Smith, Susan O'Brien, MD, Jan A. Burger, MD, PhD, William G. Wierda, MD, Alessandra Ferrajoli, MD
Journal: Blood
Blood (2013) 122 (21): 4183.
https://doi.org/10.1182/blood.V122.21.4183.4183
Published: 2013
Journal Articles

2-O, 3-O Desulfated Heparin (ODSH) May Mitigate Chemotherapy-Induced Thrombocytopenia and Neutropenia in Patients Treated with Combination Gemcitabine (G)/Nab-Paclitaxel (A), a Myelosuppressive Chemotherapy Regimen

Darren Sigal, MD, Stephen Marcus, MD, Steven J. Cohen, MD, Peter J. Rosen, MD, Tim Nguyen, MD, Thomas Gribbin, MD, Pedro M. Quintana Diez, MD, Mitesh Borad, MD
Journal: Blood
Blood (2012) 120 (21): 4723.
https://doi.org/10.1182/blood.V120.21.4723.4723
Published: 2012
Journal Articles

2-O, 3-O-Desulfated Heparin (ODSH) Mitigates Chemotherapy-Induced Thrombocytopenia (CIT) by Blocking the Negative Paracrine Effect of Platelet Factor 4 (PF4) On Megakaryopoiesis

Michele Lambert, MD, Samriddhi S Sharma, Liqing Xiao, PhD, Stephen Marcus, MD, Mortimer Poncz, MD
Journal: Blood
Blood (2012) 120 (21): 386.
https://doi.org/10.1182/blood.V120.21.386.386
Published: 2012
Journal Articles

Trousseau’s Syndrome Revisited: Tissue Factor-Bearing Microparticles in Pancreatic Cancer.

Jeffrey I. Zwicker, MD, Barbara C. Furie, PhD, Cynthia A. Kos, MS, Thomas LaRocca, Kenneth A. Bauer, MD, Bruce Furie, MD
Journal: Blood
Blood (2005) 106 (11): 259.
https://doi.org/10.1182/blood.V106.11.259.259
Published: 2005